Skip to content

Released Feb 23, 2017, after the close

10-K filed Feb 23, 2017, 54 days after period end · 0000917520-17-000010

Q4 2016 · 10-K
Revenue$255.66M+6.0% vs Q4 2015+2.1% vs Q3 2016
Net Income$28.25M+88.6% vs Q4 2015+40.2% vs Q3 2016
EPS Diluted$0.35+75.0% vs Q4 2015+40.0% vs Q3 2016
Gross Profit$170,242,000+12.6%
Operating Incomederived$40,768,000+69.8%
Operating Cash Flowderived$6,529,000−74.5%
Free Cash Flowderived-$14,663,000N/M
Margins · derived
Gross margin66.6%+3.9 pt vs Q4 2015
Operating margin15.9%+6.0 pt vs Q4 2015
Net margin11.0%+4.8 pt vs Q4 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2016Q4 2015Q4 2014Q4 2013
Revenue$255.66M$241.16M$219.07M$220.77M
Net Income$28.25M$14.98M$17.17M$13.77M
EPS Diluted$0.35$0.20$0.52$0.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR